You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Baxter
Medtronic
Johnson and Johnson
AstraZeneca

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-07-01
Court District Court, D. Delaware Date Terminated 2018-03-14
Cause 15:1126 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Both Referred To
Parties GILEAD SCIENCES INC.; IDENIX PHARMACEUTICALS INC.; IDENIX PHARMACEUTICALS LLC; JEREMY CLARK; UNIVERSITA DEGLI STUDI DI CAGLIARI
Patents 7,964,580; 8,637,475; 9,056,057
Attorneys Alicia A. Russo; Andrew Colin Mayo; AnnaMartina Tyreus Hufnal; Anthony M. Insogna; Anthony M. Zupcic; Bradley W. Harrison; Calvin P. Griffith; Douglas Edward McCann; Gregory Robert Booker; Jennifer L. Swize; Jenny Shmuel; Jeremy Clark; John D. Kinton; John G. Day; John M. Michalik; Joseph B. Warden; Lisa L. Furby; Michael P. Kelly; Michael R. Headley; Michael S. Weinstein; Rebecca Charnas Grant; Robert M. Oakes; Ryan B. McCrum; Santosh Victor Coutinho; Stephanie E. Parker; Tasha M Francis; Tharan Gregory Lanier; William Chad Shear
Firms Fish & Richardson P.C.; Jeremy Clark
Link to Docket External link to docket
Small Molecule Drugs cited in Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-05-20 117 Exhibit A pat – 91:42-53 (now US 8,637,475):  ’600 pat – 91… The ’054 patent claims (Exh. B), including: ’054 Patent Specification (Exh. B):… The ’054 patent claims (Exh. B), including: ’054 Patent Specification (Exh. B)… The ’597 patent claims (Exh. C), including: ’597 Patent Specification (Exh. C)…pyrimidine nucleoside.” The ’597 patent is a continuation of the ’054 patent and shares an identical specification External link to document
2017-02-23 536 Sofia) (testimony re DX-2721, U.S. Pat. No. 7,964,580). …portfolio of patents, not just a single patent. The Pharmasset-Roche agreement licensed every patent Pharmasset…Merck-Roche] agreement, it is for a patent, this agreement is for a patent related to Hepatitis C… an “entire patent portfolio” was “vastly different” from a license to “only one patent.”); Trell v.…licensed patents. PX-1606.11 Having failed to discuss or even identify the licensed patents, Mr. Carter External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.